Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Targeting glycolysis may help treat PCOS by improving insulin sensitivity and ovarian function.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Gray seals use more energy and have higher hormone levels during their annual fur-shedding period.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Thyroid problems can cause hair loss and change hair texture.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Thyroid disorders can cause skin issues in children, so early detection and screening are important.

HPT axis hormones boost mitochondrial function and growth in hair follicles, potentially aiding hair health.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

A young Saudi girl with uncontrolled type 1 diabetes and hypothyroidism had two rare conditions, Mauriac syndrome and Van Wyk–Grumbach syndrome.

PCOS patients with autoimmune thyroid disease have lower DHEAS levels.

Routine thyroid tests for diffuse alopecia in women may not be necessary, but checking for iron deficiency anemia could be useful.

Frequent blood transfusions in beta thalassemia can lead to thyroid problems.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Women with diffuse hair loss often have lower iron and vitamin D levels, but their thyroid function is typically normal.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

SHBG may be a useful early indicator and treatment target for PCOS.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Zinc supplements may be needed to treat hair loss in hypothyroidism.

Mutations in certain receptors can cause diseases and offer new treatment options.